Skyrocketing demand for weight loss and diabetes drugs has forced Eli Lilly and Novo Nordisk, to invest billions to increase manufacturing capacity.
Recent Posts
- Applying this ‘$1 rule’ is the secret to guilt-free shopping, expert says. Here’s how it works
- Student loan borrowers may face higher payments under Trump
- S&P 500 rises to new high in Friday’s short session, Dow heads for best month of 2024: Live updates
- Bitcoin heads for nearly 40% November gain as it edges closer to $100,000
- You’re ‘wired’ to overspend during the holidays, expert says — here’s what to do about it